+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Horizon Pharma plc - logo

Horizon Pharma plc is a biopharmaceutical company focused on developing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases. The company markets 11 medicines through its orphan, rheumatology and primary care business units, including ACTIMMUNE, BUPHENYL, DUEXIS, RAVICTI, QUINSAIR and PENNSAID. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • December 2023
  • 93 Pages
  • Global
From
Gout Therapeutics Global Market Report 2023 - Product Thumbnail Image

Gout Therapeutics Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
From
From
Systemic Sclerosis - Pipeline Insight, 2021 - Product Thumbnail Image

Systemic Sclerosis - Pipeline Insight, 2021

  • Clinical Trials
  • December 2021
  • 80 Pages
  • Global
From
From
Autoimmune Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2023

  • Report
  • October 2023
  • 450 Pages +
  • Global
From
Chronic Back Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Chronic Back Pain - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Chronic Pancreatitis Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Chronic Pancreatitis Pain - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
From
From
From
Loading Indicator